Abstract
Under the paradigm of Precision Medicine (PM), patients with the same disease can receive different personalized therapies according to their clinical and genetic features. These therapies are determined by the totality of all available clinical evidence, including results from case reports, clinical trials, and systematic reviews. However, it is increasingly difficult for physicians to find such evidence from scientific publications, whose size is growing at an unprecedented pace. In this work, we propose the PM-Search system to facilitate the retrieval of clinical literature that contains critical evidence for or against giving specific therapies to certain cancer patients. The PM-Search system combines a Baseline Retriever that selects document candidates at a large scale and an Evidence Re-ranker that finely reorders the candidates based on their evidence quality. The Baseline Retriever uses query expansion and keyword matching with the Elasticsearch retrieval engine, and the Evidence Re-ranker fits pre-trained language models to expert annotations that are derived from an active learning strategy. The PM-Search system achieves the best performance in the retrieval of high-quality clinical evidence at the TREC PM Track 2020, outperforming the second-ranking systems by large margins (0.4780 vs. 0.4238 for standard NDCG@30 and 0.4519 vs. 0.4193 for exponential NDCG@30). We present PM-Search, a state-of-the-art search engine to assist the practicing of evidence-based PM. PM-Search uses a novel BioBERT-based active learning strategy that models evidence quality and improves the model performance. Our analyses show that evidence quality is a distinct aspect from general relevance, and specific modeling of evidence quality beyond general relevance is required for a PM search engine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.